• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues.HIV治愈干预对组织中病毒储存库的影响。
Front Microbiol. 2019 Aug 21;10:1956. doi: 10.3389/fmicb.2019.01956. eCollection 2019.
2
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.HIV-1储存库:在抗病毒免疫反应和抗逆转录病毒疗法存在的情况下病毒持续存在的机制
Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665.
3
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.从组织储存库中清除HIV:治愈面临的挑战。
AIDS Res Hum Retroviruses. 2018 Jan;34(1):3-8. doi: 10.1089/AID.2017.0072. Epub 2017 Aug 7.
4
Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.马拉维若与潜伏 HIV-1 再激活有关,通过抑制性抗逆转录病毒治疗的 HIV 感染者静息 CD4 T 细胞中 NF-κB 的激活。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.01931-17. Print 2018 May 1.
5
Infectious Virus Persists in CD4 T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.在抗逆转录病毒治疗抑制的感染猴免疫缺陷病毒的猕猴的 CD4 T 细胞和巨噬细胞中持续存在传染性病毒。
J Virol. 2019 Jul 17;93(15). doi: 10.1128/JVI.00065-19. Print 2019 Aug 1.
6
Combating the HIV reservoirs.对抗 HIV 储库。
Biotechnol Genet Eng Rev. 2018 Apr;34(1):76-89. doi: 10.1080/02648725.2018.1471641. Epub 2018 May 21.
7
Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.感染猿猴免疫缺陷病毒且接受抗逆转录病毒治疗抑制的猕猴中的脑巨噬细胞:一个功能性潜伏库
mBio. 2017 Aug 15;8(4):e01186-17. doi: 10.1128/mBio.01186-17.
8
Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy.抑制性抗逆转录病毒疗法治疗下,源于中国的感染 SIV 的恒河猴的淋巴组织中存在持续性病毒储库。
Viruses. 2019 Jan 27;11(2):105. doi: 10.3390/v11020105.
9
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.HIV 储库:发病机制以及病毒清除和治愈的障碍。
AIDS. 2012 Jun 19;26(10):1261-8. doi: 10.1097/QAD.0b013e328353f3f1.
10
Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs.面对HIV-1细胞和组织储存库异质性的潜伏期逆转剂的现状
Front Microbiol. 2020 Jan 24;10:3060. doi: 10.3389/fmicb.2019.03060. eCollection 2019.

引用本文的文献

1
Provoked cytokine response is not associated with distress or induced secondary hyperalgesia in people with suppressed HIV.激发的细胞因子反应与HIV抑制人群的痛苦或诱发的继发性痛觉过敏无关。
medRxiv. 2025 Mar 11:2025.01.21.25320673. doi: 10.1101/2025.01.21.25320673.
2
Bridging brain and blood: a prospective view on neuroimaging-exosome correlations in HIV-associated neurocognitive disorders.连接大脑与血液:对HIV相关神经认知障碍中神经影像学-外泌体相关性的前瞻性观点
Front Neurol. 2025 Jan 7;15:1479272. doi: 10.3389/fneur.2024.1479272. eCollection 2024.
3
Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention.中和威胁:利用抗HIV-1的广谱中和抗体进行治疗和预防。
Microb Cell. 2024 Jul 3;11:207-220. doi: 10.15698/mic2024.07.826. eCollection 2024.
4
The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure.隧道纳米管在HIV感染和再激活早期阶段的作用:对HIV治愈的影响。
NeuroImmune Pharm Ther. 2023 Jan 4;2(2):169-186. doi: 10.1515/nipt-2022-0015. eCollection 2023 Jun.
5
Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain.鉴定、定量和表征人类大脑中的 HIV-1 储存库。
Cells. 2022 Aug 2;11(15):2379. doi: 10.3390/cells11152379.
6
The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.HIV 潜伏逆转剂 HODHBt 通过增加白细胞介素 15 介导的 STAT 激活增强 NK 细胞效应和记忆样功能。
J Virol. 2022 Aug 10;96(15):e0037222. doi: 10.1128/jvi.00372-22. Epub 2022 Jul 14.
7
Osteopontin/secreted phosphoprotein-1 harnesses glial-, immune-, and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation.骨桥蛋白/分泌磷蛋白-1 利用神经胶质细胞、免疫细胞和神经元细胞的配体 - 受体相互作用来感知和调节急性和慢性神经炎症。
Immunol Rev. 2022 Oct;311(1):224-233. doi: 10.1111/imr.13081. Epub 2022 Apr 22.
8
Functional Profile of CD8 T-Cells in Response to HLA-A*02:01-Restricted Mutated Epitopes Derived from the Gag Protein of Circulating HIV-1 Strains from Medellín, Colombia.针对来自哥伦比亚麦德林循环 HIV-1 株的 gag 蛋白中 HLA-A*02:01 限制性突变表位的 CD8 T 细胞的功能特征。
Front Immunol. 2022 Mar 22;13:793982. doi: 10.3389/fimmu.2022.793982. eCollection 2022.
9
Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers.抗逆转录病毒治疗的无病毒血症 HIV 患者和 HIV 精英控制者的神经炎症的多模态研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 9;9(2). doi: 10.1212/NXI.0000000000001144. Print 2022 Mar.
10
More than a Gender Issue: Testis as a Distinctive HIV Reservoir and Its Implication for Viral Eradication.不只是性别问题:睾丸作为 HIV 的独特储存库及其对病毒清除的意义。
Methods Mol Biol. 2022;2407:173-186. doi: 10.1007/978-1-0716-1871-4_13.

本文引用的文献

1
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.TLR9 激动剂 MGN1703 增强淋巴结中 B 细胞的分化和功能。
EBioMedicine. 2019 Jul;45:328-340. doi: 10.1016/j.ebiom.2019.07.005. Epub 2019 Jul 9.
2
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.聚肌胞苷酸(Poly-ICLC),一种 TLR3 激动剂,在经治 HIV 感染患者中诱导短暂的固有免疫反应:一项随机、双盲、安慰剂对照试验。
Front Immunol. 2019 Apr 9;10:725. doi: 10.3389/fimmu.2019.00725. eCollection 2019.
3
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.临床应用中的广谱中和抗 HIV-1 单克隆抗体。
Nat Med. 2019 Apr;25(4):547-553. doi: 10.1038/s41591-019-0412-8. Epub 2019 Apr 1.
4
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals.24 周 Toll 样受体 9 激动剂治疗对 HIV 型 1 感染者的影响。
AIDS. 2019 Jul 1;33(8):1315-1325. doi: 10.1097/QAD.0000000000002213.
5
In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals.体内给予组蛋白去乙酰化酶抑制剂不会损害 HIV 阳性个体自然杀伤细胞的功能。
AIDS. 2019 Mar 15;33(4):605-613. doi: 10.1097/QAD.0000000000002112.
6
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.分析治疗中断的 HIV 感染者血液和淋巴结中完整前病毒的特征。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01920-18. Print 2019 Apr 15.
7
Relationship between intact HIV-1 proviruses in circulating CD4 T cells and rebound viruses emerging during treatment interruption.循环 CD4 T 细胞中完整 HIV-1 前病毒与治疗中断期间出现的反弹病毒之间的关系。
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11341-E11348. doi: 10.1073/pnas.1813512115. Epub 2018 Nov 12.
8
Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial.群体药代动力学和药效学研究:双硫仑在 IIb 期临床试验中诱导潜伏 HIV-1 转录的作用。
Clin Pharmacol Ther. 2019 Mar;105(3):692-702. doi: 10.1002/cpt.1220. Epub 2018 Oct 9.
9
Clinical Interventions in HIV Cure Research.HIV 治愈研究中的临床干预措施。
Adv Exp Med Biol. 2018;1075:285-318. doi: 10.1007/978-981-13-0484-2_12.
10
In Vitro and In Vivo Models of HIV Latency.HIV 潜伏的体外和体内模型。
Adv Exp Med Biol. 2018;1075:241-263. doi: 10.1007/978-981-13-0484-2_10.

HIV治愈干预对组织中病毒储存库的影响。

Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues.

作者信息

Denton Paul W, Søgaard Ole S, Tolstrup Martin

机构信息

Department of Biology, University of Nebraska Omaha, Omaha, NE, United States.

Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

Front Microbiol. 2019 Aug 21;10:1956. doi: 10.3389/fmicb.2019.01956. eCollection 2019.

DOI:10.3389/fmicb.2019.01956
PMID:31497010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6712158/
Abstract

HIV reservoirs persist in infected individuals despite combination antiretroviral therapy and can be identified in secondary lymphoid tissues, in intestinal tissues, in the central nervous system as well as in blood. Clinical trials have begun to explore effects of small molecule interventions to perturb the latent viral infection, but only limited information is available regarding the impacts of HIV cure-related clinical interventions on viral reservoirs found in tissues. Of the 14 HIV cure-related clinical trials since 2012 that have evaluated the effects of small molecule interventions , four trials have examined the impacts of the interventions in peripheral blood as well as other tissues that harbor persistent HIV. The additional tissues examined include cerebral spinal fluid, intestines and lymph nodes. We provide a comparison contrast analyses of the data across anatomical compartments tested in these studies to reveal where peripheral blood analyses reflect outcomes in other tissues as well as where the data reveal differences between tissue outcomes. We also summarize the current knowledge on these topics and highlight key open questions that need to be addressed experimentally to move the HIV cure research field closer to the development of an intervention strategy capable of eliciting long-term antiretroviral free remission of HIV disease.

摘要

尽管采用了联合抗逆转录病毒疗法,HIV储存库仍存在于受感染个体中,并且可以在次级淋巴组织、肠道组织、中枢神经系统以及血液中被识别出来。临床试验已开始探索小分子干预措施对潜伏病毒感染的影响,但关于与HIV治愈相关的临床干预措施对组织中病毒储存库的影响,目前仅有有限的信息。自2012年以来,在评估小分子干预措施效果的14项与HIV治愈相关的临床试验中,有四项试验研究了这些干预措施对外周血以及其他携带持续性HIV的组织的影响。所检测的其他组织包括脑脊液、肠道和淋巴结。我们对这些研究中所测试的不同解剖区域的数据进行了比较分析,以揭示外周血分析在哪些方面反映了其他组织的结果,以及数据在哪些方面揭示了组织结果之间的差异。我们还总结了关于这些主题的当前知识,并强调了一些关键的开放性问题,这些问题需要通过实验来解决,以便使HIV治愈研究领域更接近开发出一种能够引发HIV疾病长期无抗逆转录病毒治疗缓解的干预策略。